Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 11th October 2017
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Norbook recalls pain relief treatment
Norbrook has issued a recall for Meloxaid oral suspension for dogs and cats.
Manufacturer confirms increase of pH in certain batches

The Veterinary Medicines Directorate (VMD) has issued a product recall alert for Meloxaid Oral Suspension for Dogs and Cats.

In a statement, the VMD said: “We wish to make wholesalers and veterinary surgeons, aware that Norbrook Laboratories Ltd has issued a recall for Meloxaid 5mg/ml Solution for Injection for Dogs and Cats (Vm 02000/4397).

“Norbrook have verified that the pH of certain batches has increased over time and is out of specification.”

The issue affects batch numbers 6094-93B (Expiry Date: 03/2019, 10ml pack) and 6094-94M (Expiry Date: 03/2019, 20ml pack).

Any queries should be directed to Ms Anita Vanderlaan at Norbrook Laboratories Ltd. Tel 028 3026 4435. Email: anita.vanderlaan@norbrook.co.uk

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.